BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N, Akao Y. Decreased expression of microRNA-143 and -145 in human gastric cancers. Oncology. 2009;77:12-21. [PMID: 19439999 DOI: 10.1159/000218166] [Cited by in Crossref: 201] [Cited by in F6Publishing: 205] [Article Influence: 15.5] [Reference Citation Analysis]
Number Citing Articles
1 Dixon DA, Blanco FF, Bruno A, Patrignani P. Mechanistic aspects of COX-2 expression in colorectal neoplasia. Recent Results Cancer Res. 2013;191:7-37. [PMID: 22893198 DOI: 10.1007/978-3-642-30331-9_2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.3] [Reference Citation Analysis]
2 Yuan Y, Yang Z, Zou Q. MiRNA-145 Induces Apoptosis in a Gallbladder Carcinoma Cell Line by Targeting DFF45. Open Life Sci 2018;13:227-35. [PMID: 33817087 DOI: 10.1515/biol-2018-0027] [Reference Citation Analysis]
3 Martignetti L, Laud-Duval K, Tirode F, Pierron G, Reynaud S, Barillot E, Delattre O, Zinovyev A. Antagonism pattern detection between microRNA and target expression in Ewing's sarcoma. PLoS One 2012;7:e41770. [PMID: 22848594 DOI: 10.1371/journal.pone.0041770] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
4 Chu H, Zhong D, Tang J, Li J, Xue Y, Tong N, Qin C, Yin C, Zhang Z, Wang M. A functional variant in miR-143 promoter contributes to prostate cancer risk. Arch Toxicol 2016;90:403-14. [PMID: 25354797 DOI: 10.1007/s00204-014-1396-2] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
5 Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang Y, Ye S, Wu S, Zhong G, Ren J, Zhang Y, Liu L, Zhu W. MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci 2013;9:680-92. [PMID: 23904792 DOI: 10.7150/ijbs.6623] [Cited by in Crossref: 48] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
6 Emami SS, Akbari A, Zare AA, Agah S, Masoodi M, Talebi A, Minaeian S, Fattahi A, Moghadamnia F. MicroRNA Expression Levels and Histopathological Features of Colorectal Cancer. J Gastrointest Cancer 2019;50:276-84. [PMID: 29404790 DOI: 10.1007/s12029-018-0055-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
7 Yang W, Ma J, Zhou W, Cao B, Zhou X, Yang Z, Zhang H, Zhao Q, Fan D, Hong L. Molecular mechanisms and theranostic potential of miRNAs in drug resistance of gastric cancer. Expert Opin Ther Targets. 2017;21:1063-1075. [PMID: 28994330 DOI: 10.1080/14728222.2017.1389900] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
8 Li B, Rao N, Liu D, Yang Y, Liu D, Li Y, Liu H, Gan T, Ding H, Lin H. Analysis of connection networks among miRNAs differentially expressed in early gastric cancer for disclosing some biological features of disease development. Gene 2014;548:159-65. [PMID: 25014139 DOI: 10.1016/j.gene.2014.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Cabibi D, Caruso S, Bazan V, Castiglia M, Bronte G, Ingrao S, Fanale D, Cangemi A, Calò V, Listì A, Incorvaia L, Galvano A, Pantuso G, Fiorentino E, Castorina S, Russo A. Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus. Oncotarget 2016;7:47821-30. [PMID: 27374102 DOI: 10.18632/oncotarget.10291] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
10 Ishiguro H, Kimura M, Takeyama H. Role of microRNAs in gastric cancer. World J Gastroenterol 2014; 20(19): 5694-5699 [PMID: 24914330 DOI: 10.3748/wjg.v20.i19.5694] [Cited by in CrossRef: 51] [Cited by in F6Publishing: 43] [Article Influence: 6.4] [Reference Citation Analysis]
11 Fernández-carrillo C, Pérez-vilaró G, Díez J, Pérez-del-pulgar S. Hepatitis C virus plays with fire and yet avoids getting burned. A review for clinicians on processing bodies and stress granules. Liver Int 2018;38:388-98. [DOI: 10.1111/liv.13541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
12 He X, Shu Y. miR-452 promotes the development of gastric cancer via targeting EPB41L3. Pathology - Research and Practice 2020;216:152725. [DOI: 10.1016/j.prp.2019.152725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
13 Peschiaroli A, Giacobbe A, Formosa A, Markert EK, Bongiorno-Borbone L, Levine AJ, Candi E, D’Alessandro A, Zolla L, Finazzi Agrò A. miR-143 regulates hexokinase 2 expression in cancer cells. Oncogene. 2013;32:797-802. [PMID: 22469988 DOI: 10.1038/onc.2012.100] [Cited by in Crossref: 114] [Cited by in F6Publishing: 122] [Article Influence: 11.4] [Reference Citation Analysis]
14 Gomes SE, Simões AE, Pereira DM, Castro RE, Rodrigues CM, Borralho PM. miR-143 or miR-145 overexpression increases cetuximab-mediated antibody-dependent cellular cytotoxicity in human colon cancer cells. Oncotarget 2016;7:9368-87. [PMID: 26824186 DOI: 10.18632/oncotarget.7010] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
15 Pagliuca A, Valvo C, Fabrizi E, di Martino S, Biffoni M, Runci D, Forte S, De Maria R, Ricci-Vitiani L. Analysis of the combined action of miR-143 and miR-145 on oncogenic pathways in colorectal cancer cells reveals a coordinate program of gene repression. Oncogene. 2013;32:4806-4813. [PMID: 23128394 DOI: 10.1038/onc.2012.495] [Cited by in Crossref: 124] [Cited by in F6Publishing: 122] [Article Influence: 12.4] [Reference Citation Analysis]
16 Dou L, Zheng D, Li J, Li Y, Gao L, Wang L, Yu L. Methylation-mediated repression of microRNA-143 enhances MLL-AF4 oncogene expression. Oncogene. 2012;31:507-517. [PMID: 21706045 DOI: 10.1038/onc.2011.248] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
17 Accordino G, Lettieri S, Bortolotto C, Benvenuti S, Gallotti A, Gattoni E, Agustoni F, Pozzi E, Rinaldi P, Primiceri C, Morbini P, Lancia A, Stella GM. From Interconnection between Genes and Microenvironment to Novel Immunotherapeutic Approaches in Upper Gastro-Intestinal Cancers-A Multidisciplinary Perspective. Cancers (Basel) 2020;12:E2105. [PMID: 32751137 DOI: 10.3390/cancers12082105] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Gao W, Sun W, Yin J, Lv X, Bao J, Yu J, Wang L, Jin C, Hu L. Screening candidate microRNAs (miRNAs) in different lambskin hair follicles in Hu sheep. PLoS One 2017;12:e0176532. [PMID: 28464030 DOI: 10.1371/journal.pone.0176532] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
19 Takai T, Yoshikawa Y, Inamoto T, Minami K, Taniguchi K, Sugito N, Kuranaga Y, Shinohara H, Kumazaki M, Tsujino T, Takahara K, Ito Y, Akao Y, Azuma H. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells. Int J Mol Sci 2017;18:E179. [PMID: 28106737 DOI: 10.3390/ijms18010179] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
20 Li Y, Kong D, Wang Z, Sarkar FH. Regulation of microRNAs by natural agents: an emerging field in chemoprevention and chemotherapy research. Pharm Res 2010;27:1027-41. [PMID: 20306121 DOI: 10.1007/s11095-010-0105-y] [Cited by in Crossref: 141] [Cited by in F6Publishing: 117] [Article Influence: 11.8] [Reference Citation Analysis]
21 Sun G, Cheng YW, Lai L, Huang TC, Wang J, Wu X, Wang Y, Huang Y, Wang J, Zhang K. Signature miRNAs in colorectal cancers were revealed using a bias reduction small RNA deep sequencing protocol. Oncotarget. 2016;7:3857-3872. [PMID: 26646696 DOI: 10.18632/oncotarget.6460] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
22 Aviñó A, Huertas CS, Lechuga LM, Eritja R. Sensitive and label-free detection of miRNA-145 by triplex formation. Anal Bioanal Chem 2016;408:885-93. [DOI: 10.1007/s00216-015-9180-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
23 Spaety ME, Gries A, Badie A, Venkatasamy A, Romain B, Orvain C, Yanagihara K, Okamoto K, Jung AC, Mellitzer G, Pfeffer S, Gaiddon C. HDAC4 Levels Control Sensibility toward Cisplatin in Gastric Cancer via the p53-p73/BIK Pathway. Cancers (Basel) 2019;11:E1747. [PMID: 31703394 DOI: 10.3390/cancers11111747] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
24 Feng R, Chen X, Yu Y, Su L, Yu B, Li J, Cai Q, Yan M, Liu B, Zhu Z. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett. 2010;298:50-63. [PMID: 20619534 DOI: 10.1016/j.canlet.2010.06.004] [Cited by in Crossref: 194] [Cited by in F6Publishing: 192] [Article Influence: 16.2] [Reference Citation Analysis]
25 Yang S, Wang S, Luo A, Ding T, Lai Z, Shen W, Ma X, Cao C, Shi L, Jiang J, Rong F, Ma L, Tian Y, Du X, Lu Y, Li Y, Wang S. Expression Patterns and Regulatory Functions of MicroRNAs During the Initiation of Primordial Follicle Development in the Neonatal Mouse Ovary1. Biology of Reproduction 2013;89. [DOI: 10.1095/biolreprod.113.107730] [Cited by in Crossref: 39] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
26 Ma L, Li LL. miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1. Cell Transplant 2019;28:1299-305. [PMID: 31271056 DOI: 10.1177/0963689719861063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
27 Fan L, Wu Q, Xing X, Wei Y, Shao Z. MicroRNA-145 targets vascular endothelial growth factor and inhibits invasion and metastasis of osteosarcoma cells. Acta Biochim Biophys Sin (Shanghai) 2012;44:407-14. [PMID: 22472569 DOI: 10.1093/abbs/gms019] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 7.0] [Reference Citation Analysis]
28 Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G, Liu Q, Du J. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene. 2013;517:197-204. [PMID: 23276710 DOI: 10.1016/j.gene.2012.12.031] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 4.9] [Reference Citation Analysis]
29 Smith CM, Michael MZ, Watson DI, Tan G, Astill DS, Hummel R, Hussey DJ. Impact of gastro-oesophageal reflux on microRNA expression, location and function. BMC Gastroenterol 2013;13:4. [PMID: 23297865 DOI: 10.1186/1471-230X-13-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
30 Ren K, Li Z, Li Y, Zhang W, Han X. Long Noncoding RNA Taurine-Upregulated Gene 1 Promotes Cell Proliferation and Invasion in Gastric Cancer via Negatively Modulating miRNA-145-5p. Oncol Res 2017;25:789-98. [PMID: 27983921 DOI: 10.3727/096504016X14783677992682] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
31 Jiang SB, He XJ, Xia YJ, Hu WJ, Luo JG, Zhang J, Tao HQ. MicroRNA-145-5p inhibits gastric cancer invasiveness through targeting N-cadherin and ZEB2 to suppress epithelial-mesenchymal transition. Onco Targets Ther 2016;9:2305-15. [PMID: 27143926 DOI: 10.2147/OTT.S101853] [Cited by in Crossref: 9] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
32 Yan H, Wang S, Yu H, Zhu J, Chen C. Molecular pathways and functional analysis of miRNA expression associated with paclitaxel-induced apoptosis in hepatocellular carcinoma cells. Pharmacology 2013;92:167-74. [PMID: 24060847 DOI: 10.1159/000354585] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
33 Borralho PM, Simões AE, Gomes SE, Lima RT, Carvalho T, Ferreira DM, Vasconcelos MH, Castro RE, Rodrigues CM. miR-143 overexpression impairs growth of human colon carcinoma xenografts in mice with induction of apoptosis and inhibition of proliferation. PLoS One. 2011;6:e23787. [PMID: 21901135 DOI: 10.1371/journal.pone.0023787] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 6.5] [Reference Citation Analysis]
34 Guillem-llobat P, Dovizio M, Alberti S, Bruno A, Patrignani P. Platelets, Cyclooxygenases, and Colon Cancer. Seminars in Oncology 2014;41:385-96. [DOI: 10.1053/j.seminoncol.2014.04.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.1] [Reference Citation Analysis]
35 Das AV, Pillai RM. Implications of miR cluster 143/145 as universal anti-oncomiRs and their dysregulation during tumorigenesis. Cancer Cell Int 2015;15:92. [PMID: 26425114 DOI: 10.1186/s12935-015-0247-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
36 Yang Y, Chaerkady R, Kandasamy K, Huang TC, Selvan LD, Dwivedi SB, Kent OA, Mendell JT, Pandey A. Identifying targets of miR-143 using a SILAC-based proteomic approach. Mol Biosyst. 2010;6:1873-1882. [PMID: 20544124 DOI: 10.1039/c00401f] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Kang W, Tong JH, Chan AW, Lung RW, Chau SL, Wong QW, Wong N, Yu J, Cheng AS, To KF. Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer. PLoS One. 2012;7:e33919. [PMID: 22470493 DOI: 10.1371/journal.pone.0033919] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
38 Li M, Li J, Ding X, He M, Cheng SY. microRNA and cancer. AAPS J 2010;12:309-17. [PMID: 20422339 DOI: 10.1208/s12248-010-9194-0] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 8.3] [Reference Citation Analysis]
39 Kent OA, McCall MN, Cornish TC, Halushka MK. Lessons from miR-143/145: the importance of cell-type localization of miRNAs. Nucleic Acids Res 2014;42:7528-38. [PMID: 24875473 DOI: 10.1093/nar/gku461] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 16.8] [Reference Citation Analysis]
40 Findlay VJ, Wang C, Nogueira LM, Hurst K, Quirk D, Ethier SP, Staveley O'Carroll KF, Watson DK, Camp ER. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Mol Cancer Ther 2014;13:2713-26. [PMID: 25249558 DOI: 10.1158/1535-7163.MCT-14-0207] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
41 Izadpanah S, Shabani P, Aghebati-Maleki A, Baghbani E, Baghbanzadeh A, Fotouhi A, Bakhshinejad B, Aghebati-Maleki L, Baradaran B. Insights into the roles of miRNAs; miR-193 as one of small molecular silencer in osteosarcoma therapy. Biomed Pharmacother 2019;111:873-81. [PMID: 30841466 DOI: 10.1016/j.biopha.2018.12.106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
42 Ali AS, Ali S, Ahmad A, Bao B, Philip PA, Sarkar FH. Expression of microRNAs: potential molecular link between obesity, diabetes and cancer. Obesity reviews : an official journal of the International Association for the Study of Obesity. 2011;12:1050-1062. [PMID: 21767342 DOI: 10.1111/j.1467-789x.2011.00906.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
43 Chivukula RR, Shi G, Acharya A, Mills EW, Zeitels LR, Anandam JL, Abdelnaby AA, Balch GC, Mansour JC, Yopp AC. An essential mesenchymal function for miR-143/145 in intestinal epithelial regeneration. Cell. 2014;157:1104-1116. [PMID: 24855947 DOI: 10.1016/j.cell.2014.03.055] [Cited by in Crossref: 138] [Cited by in F6Publishing: 134] [Article Influence: 17.3] [Reference Citation Analysis]
44 Saito K, Inagaki K, Kamimoto T, Ito Y, Sugita T, Nakajo S, Hirasawa A, Iwamaru A, Ishikura T, Hanaoka H, Okubo K, Onozaki T, Zama T. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PLoS One 2013;8:e71480. [PMID: 23967217 DOI: 10.1371/journal.pone.0071480] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.2] [Reference Citation Analysis]
45 Kang YT, Hsu WC, Wu CH, Hsin IL, Wu PR, Yeh KT, Ko JL. Metformin alleviates nickel-induced autophagy and apoptosis via inhibition of hexokinase-2, activating lipocalin-2, in human bronchial epithelial cells. Oncotarget 2017;8:105536-52. [PMID: 29285270 DOI: 10.18632/oncotarget.22317] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
46 Jia QN, Zeng YP. Rapamycin blocks the IL-13-induced deficiency of Epidermal Barrier Related Proteins via upregulation of miR-143 in HaCaT Keratinocytes. Int J Med Sci 2020;17:2087-94. [PMID: 32922169 DOI: 10.7150/ijms.45765] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Wu WY, Xue XY, Chen ZJ, Han SL, Huang YP, Zhang LF, Zhu GB, Shen X. Potentially predictive microRNAs of gastric cancer with metastasis to lymph node. World J Gastroenterol 2011; 17(31): 3645-3651 [PMID: 21987613 DOI: 10.3748/wjg.v17.i31.3645] [Cited by in CrossRef: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
48 Yang Q, Jie Z, Cao H, Greenlee AR, Yang C, Zou F, Jiang Y. Low-level expression of let-7a in gastric cancer and its involvement in tumorigenesis by targeting RAB40C. Carcinogenesis. 2011;32:713-722. [PMID: 21349817 DOI: 10.1093/carcin/bgr035] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
49 Taniguchi K, Sugito N, Kumazaki M, Shinohara H, Yamada N, Matsuhashi N, Futamura M, Ito Y, Otsuki Y, Yoshida K, Uchiyama K, Akao Y. Positive feedback of DDX6/c-Myc/PTB1 regulated by miR-124 contributes to maintenance of the Warburg effect in colon cancer cells. Biochim Biophys Acta 2015;1852:1971-80. [PMID: 26144048 DOI: 10.1016/j.bbadis.2015.06.022] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 4.7] [Reference Citation Analysis]
50 Davis-Dusenbery BN, Chan MC, Reno KE, Weisman AS, Layne MD, Lagna G, Hata A. down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4. J Biol Chem 2011;286:28097-110. [PMID: 21673106 DOI: 10.1074/jbc.M111.236950] [Cited by in Crossref: 177] [Cited by in F6Publishing: 107] [Article Influence: 16.1] [Reference Citation Analysis]
51 Tokumaru Y, Tajirika T, Sugito N, Kuranaga Y, Shinohara H, Tsujino T, Matsuhashi N, Futamura M, Akao Y, Yoshida K. Synthetic miR-143 Inhibits Growth of HER2-Positive Gastric Cancer Cells by Suppressing KRAS Networks Including DDX6 RNA Helicase. Int J Mol Sci 2019;20:E1697. [PMID: 30959742 DOI: 10.3390/ijms20071697] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
52 Lin H, You B, Lin X, Wang X, Zhou D, Chen Z, Chen Y, Wang R. Silencing of long non-coding RNA Sox2ot inhibits oxidative stress and inflammation of vascular smooth muscle cells in abdominal aortic aneurysm via microRNA-145-mediated Egr1 inhibition. Aging (Albany NY) 2020;12:12684-702. [PMID: 32629426 DOI: 10.18632/aging.103077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
53 Hu Y, Ma Z, He Y, Liu W, Su Y, Tang Z. PART-1 functions as a competitive endogenous RNA for promoting tumor progression by sponging miR-143 in colorectal cancer. Biochem Biophys Res Commun 2017;490:317-23. [PMID: 28619512 DOI: 10.1016/j.bbrc.2017.06.042] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
54 Zhang W, Wang Q, Yu M, Wu N, Wang H. MicroRNA-145 function as a cell growth repressor by directly targeting c-Myc in human ovarian cancer. Technol Cancer Res Treat 2014;13:161-8. [PMID: 23919393 DOI: 10.7785/tcrt.2012.500367] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.4] [Reference Citation Analysis]
55 Shinohara H, Kuranaga Y, Kumazaki M, Sugito N, Yoshikawa Y, Takai T, Taniguchi K, Ito Y, Akao Y. Regulated Polarization of Tumor-Associated Macrophages by miR-145 via Colorectal Cancer-Derived Extracellular Vesicles. J Immunol 2017;199:1505-15. [PMID: 28696255 DOI: 10.4049/jimmunol.1700167] [Cited by in Crossref: 70] [Cited by in F6Publishing: 75] [Article Influence: 14.0] [Reference Citation Analysis]
56 Chiyomaru T, Enokida H, Tatarano S, Kawahara K, Uchida Y, Nishiyama K, Fujimura L, Kikkawa N, Seki N, Nakagawa M. miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer. Br J Cancer. 2010;102:883-891. [PMID: 20160723 DOI: 10.1038/sj.bjc.6605570] [Cited by in Crossref: 241] [Cited by in F6Publishing: 226] [Article Influence: 20.1] [Reference Citation Analysis]
57 Zhuang M, Shi Q, Zhang X, Ding Y, Shan L, Shan X, Qian J, Zhou X, Huang Z, Zhu W, Ding Y, Cheng W, Liu P, Shu Y. Involvement of miR-143 in cisplatin resistance of gastric cancer cells via targeting IGF1R and BCL2. Tumour Biol. 2015;36:2737-2745. [PMID: 25492481 DOI: 10.1007/s13277-014-2898-5] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 4.9] [Reference Citation Analysis]
58 Yin Y, Yan ZP, Lu NN, Xu Q, He J, Qian X, Yu J, Guan X, Jiang BH, Liu LZ. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1. Biochim Biophys Acta. 2013;1829:239-247. [PMID: 23201159 DOI: 10.1016/j.bbagrm.2012.11.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
59 Shao Y, Zhang SQ, Quan F, Zhang PF, Wu SL. MicroRNA-145 inhibits the proliferation, migration and invasion of the human TCA8113 oral cancer line. Oncol Lett 2013;6:1636-40. [PMID: 24273601 DOI: 10.3892/ol.2013.1621] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
60 Jin C, Wang A, Liu L, Wang G, Li G, Han Z. miR‐145‐5p inhibits tumor occurrence and metastasis through the NF‐κB signaling pathway by targeting TLR4 in malignant melanoma. J Cell Biochem 2019;120:11115-26. [DOI: 10.1002/jcb.28388] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
61 Chen JJ, Cai WY, Liu XW, Luo QC, Chen G, Huang WF, Li N, Cai JC. Reverse Correlation between MicroRNA-145 and FSCN1 Affecting Gastric Cancer Migration and Invasion. PLoS One. 2015;10:e0126890. [PMID: 26010149 DOI: 10.1371/journal.pone.0126890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
62 Tong JL, Zhang CP, Nie F, Xu XT, Zhu MM, Xiao SD, Ran ZH. MicroRNA 506 regulates expression of PPAR alpha in hydroxycamptothecin-resistant human colon cancer cells. FEBS Lett. 2011;585:3560-3568. [PMID: 22036718 DOI: 10.1016/j.febslet.2011.10.021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 5.2] [Reference Citation Analysis]
63 Yang Y, Chaerkady R, Kandasamy K, Huang TC, Selvan LD, Dwivedi SB, Kent OA, Mendell JT, Pandey A. Identifying targets of miR-143 using a SILAC-based proteomic approach. Mol Biosyst 2010;6:1873-82. [PMID: 20544124 DOI: 10.1039/c004401f] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 4.2] [Reference Citation Analysis]
64 Zhou H, Gao Z, Wan F. Taurine-upregulated gene 1 contributes to cancers through sponging microRNA. Acta Biochim Biophys Sin (Shanghai) 2019;51:123-30. [PMID: 30590378 DOI: 10.1093/abbs/gmy156] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
65 Zhang Q, Feng Y, Liu P, Yang J. MiR-143 inhibits cell proliferation and invasion by targeting DNMT3A in gastric cancer. Tumour Biol 2017;39:1010428317711312. [PMID: 28718369 DOI: 10.1177/1010428317711312] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
66 Kopp F, Schnoedt M, Haase R, Wagner E, Roidl A, Ogris M. De-targeting by miR-143 decreases unwanted transgene expression in non-tumorigenic cells. Gene Ther 2013;20:1104-9. [PMID: 23804075 DOI: 10.1038/gt.2013.37] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
67 Yamagata T, Yoshizawa J, Ohashi S, Yanaga K, Ohki T. Expression patterns of microRNAs are altered in hypoxic human neuroblastoma cells. Pediatr Surg Int 2010;26:1179-84. [PMID: 20809117 DOI: 10.1007/s00383-010-2700-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
68 Sarver AL, Phalak R, Thayanithy V, Subramanian S. S-MED: Sarcoma microRNA Expression Database. Lab Invest 2010;90:753-61. [DOI: 10.1038/labinvest.2010.53] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 6.7] [Reference Citation Analysis]
69 Zhao WG, Yu SN, Lu ZH, Ma YH, Gu YM, Chen J. The miR-217 microRNA functions as a potential tumor suppressor in pancreatic ductal adenocarcinoma by targeting KRAS. Carcinogenesis. 2010;31:1726-1733. [PMID: 20675343 DOI: 10.1093/carcin/bgq160] [Cited by in Crossref: 156] [Cited by in F6Publishing: 158] [Article Influence: 13.0] [Reference Citation Analysis]
70 Sui H, Lou A, Li Z, Yang J. Lidocaine inhibits growth, migration and invasion of gastric carcinoma cells by up-regulation of miR-145. BMC Cancer 2019;19:233. [PMID: 30876463 DOI: 10.1186/s12885-019-5431-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 5.7] [Reference Citation Analysis]
71 Kobayashi E, Hornicek FJ, Duan Z. MicroRNA Involvement in Osteosarcoma. Sarcoma 2012;2012:359739. [PMID: 22550419 DOI: 10.1155/2012/359739] [Cited by in Crossref: 84] [Cited by in F6Publishing: 96] [Article Influence: 8.4] [Reference Citation Analysis]
72 Jiang X, Wang W, Yang Y, Du L, Yang X, Wang L, Zheng G, Duan W, Wang R, Zhang X, Wang L, Chen X, Wang C. Identification of circulating microRNA signatures as potential noninvasive biomarkers for prediction and prognosis of lymph node metastasis in gastric cancer. Oncotarget. 2017;8:65132-65142. [PMID: 29029418 DOI: 10.18632/oncotarget.17789] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
73 Prinz C, Weber D. MicroRNA (miR) dysregulation during Helicobacter pylori-induced gastric inflammation and cancer development: critical importance of miR-155. Oncotarget 2020;11:894-904. [PMID: 32206186 DOI: 10.18632/oncotarget.27520] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
74 Bufalino A, Cervigne NK, de Oliveira CE, Fonseca FP, Rodrigues PC, Macedo CC, Sobral LM, Miguel MC, Lopes MA, Paes Leme AF, Lambert DW, Salo TA, Kowalski LP, Graner E, Coletta RD. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis. PLoS One 2015;10:e0136599. [PMID: 26317418 DOI: 10.1371/journal.pone.0136599] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 5.3] [Reference Citation Analysis]
75 Zhang Z, Li Z, Li Y, Zang A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther 2014;21:305-16. [PMID: 25060632 DOI: 10.1038/cgt.2014.37] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 3.9] [Reference Citation Analysis]
76 Gong Z, Huang W, Wang B, Liang N, Long S, Li W, Zhou Q. Interplay between cyclooxygenase‑2 and microRNAs in cancer (Review). Mol Med Rep 2021;23:347. [PMID: 33760116 DOI: 10.3892/mmr.2021.11986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
77 Kim MK, Lee SK, Park JH, Lee JH, Yun BH, Park JH, Seo SK, Cho S, Choi YS. Ginsenoside Rg3 Decreases Fibrotic and Invasive Nature of Endometriosis by Modulating miRNA-27b: In Vitro and In Vivo Studies. Sci Rep 2017;7:17670. [PMID: 29247225 DOI: 10.1038/s41598-017-17956-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
78 Hernández R, Sánchez-Jiménez E, Melguizo C, Prados J, Rama AR. Downregulated microRNAs in the colorectal cancer: diagnostic and therapeutic perspectives. BMB Rep 2018;51:563-71. [PMID: 30158023 [PMID: 30158023 DOI: 10.5483/bmbrep.2018.51.11.116] [Cited by in Crossref: 13] [Article Influence: 4.3] [Reference Citation Analysis]
79 Gao JS, Zhang Y, Tang X, Tucker LD, Tarwater PM, Quesenberry PJ, Rigoutsos I, Ramratnam B. The Evi1, microRNA-143, K-Ras axis in colon cancer. FEBS Lett 2011;585:693-9. [PMID: 21276449 DOI: 10.1016/j.febslet.2011.01.033] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
80 Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M. microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep. 2012;27:1019-1026. [PMID: 22267008 DOI: 10.3892/or.2012.1645] [Cited by in Crossref: 182] [Cited by in F6Publishing: 180] [Article Influence: 18.2] [Reference Citation Analysis]
81 He S, Yu G, Peng K, Liu S. MicroRNA‑145‑5p suppresses fascin to inhibit the invasion and migration of cervical carcinoma cells. Mol Med Rep 2020;22:5282-92. [PMID: 33174029 DOI: 10.3892/mmr.2020.11592] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
82 Liu B, Li R, Zhang J, Meng C, Zhang J, Song X, Lv C. MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis. Exp Mol Med 2018;50:e465. [PMID: 29869625 DOI: 10.1038/emm.2017.311] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
83 Iio A, Takagi T, Miki K, Naoe T, Nakayama A, Akao Y. DDX6 post-transcriptionally down-regulates miR-143/145 expression through host gene NCR143/145 in cancer cells. Biochim Biophys Acta. 2013;1829:1102-1110. [PMID: 23932921 DOI: 10.1016/j.bbagrm.2013.07.010] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
84 Magnelli L, Schiavone N, Staderini F, Biagioni A, Papucci L. MAP Kinases Pathways in Gastric Cancer. Int J Mol Sci 2020;21:E2893. [PMID: 32326163 DOI: 10.3390/ijms21082893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
85 Ricciuti B, Mecca C, Crinò L, Baglivo S, Cenci M, Metro G. Non-coding RNAs in lung cancer. Oncoscience 2014;1:674-705. [PMID: 25593996 DOI: 10.18632/oncoscience.98] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
86 Ding L, Xu Y, Zhang W, Deng Y, Si M, Du Y, Yao H, Liu X, Ke Y, Si J, Zhou T. MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2. Cell Res. 2010;20:784-793. [PMID: 20548334 DOI: 10.1038/cr.2010.79] [Cited by in Crossref: 249] [Cited by in F6Publishing: 235] [Article Influence: 20.8] [Reference Citation Analysis]
87 Piatopoulou D, Avgeris M, Drakaki I, Marmarinos A, Xagorari M, Baka M, Pourtsidis A, Kossiva L, Gourgiotis D, Scorilas A. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia. Ann Hematol 2018;97:1169-82. [PMID: 29556721 DOI: 10.1007/s00277-018-3292-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
88 Taniguchi K, Iwatsuki A, Sugito N, Shinohara H, Kuranaga Y, Oshikawa Y, Tajirika T, Futamura M, Yoshida K, Uchiyama K, Akao Y. Oncogene RNA helicase DDX6 promotes the process of c-Myc expression in gastric cancer cells. Mol Carcinog 2018;57:579-89. [PMID: 29314290 DOI: 10.1002/mc.22781] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
89 Shin VY, Chu KM. MiRNA as potential biomarkers and therapeutic targets for gastric cancer. World J Gastroenterol 2014; 20(30): 10432-10439 [PMID: 25132759 DOI: 10.3748/wjg.v20.i30.10432] [Cited by in CrossRef: 152] [Cited by in F6Publishing: 154] [Article Influence: 19.0] [Reference Citation Analysis]
90 Chen JH, Yang R, Zhang W, Wang YP. Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma. Exp Ther Med 2016;12:3749-55. [PMID: 28101165 DOI: 10.3892/etm.2016.3847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
91 Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Kamiya Y, Ishizuka T, Nakagawa Y, Nagasaka M, Iwata M, Arisawa T, Hirata I. Association between common genetic variants in pre-microRNAs and the clinicopathological characteristics and survival of gastric cancer patients. Exp Ther Med 2010;1:1035-40. [PMID: 22993637 DOI: 10.3892/etm.2010.154] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
92 Moore AE, Young LE, Dixon DA. MicroRNA and AU-rich element regulation of prostaglandin synthesis. Cancer Metastasis Rev. 2011;30:419-435. [PMID: 22005950 DOI: 10.1007/s10555-011-9300-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
93 Akao Y, Khoo F, Kumazaki M, Shinohara H, Miki K, Yamada N. Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells. Int J Mol Sci. 2014;15:1392-1401. [PMID: 24447928 DOI: 10.3390/ijms15011392] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 6.4] [Reference Citation Analysis]
94 Melck AL, Yip L. Predicting malignancy in thyroid nodules: molecular advances. Head Neck 2012;34:1355-61. [PMID: 21818817 DOI: 10.1002/hed.21818] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
95 Otani K, Li X, Arakawa T, Chan FK, Yu J. Epigenetic-mediated tumor suppressor genes as diagnostic or prognostic biomarkers in gastric cancer. Expert Rev Mol Diagn. 2013;13:445-455. [PMID: 23782252 DOI: 10.1586/erm.13.32] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 3.2] [Reference Citation Analysis]
96 Huang J, He Y, Mcleod HL, Xie Y, Xiao D, Hu H, Chen P, Shen L, Zeng S, Yin X, Ge J, Li L, Tang L, Ma J, Chen Z. miR-302b inhibits tumorigenesis by targeting EphA2 via Wnt/ β-catenin/EMT signaling cascade in gastric cancer. BMC Cancer 2017;17:886. [PMID: 29273006 DOI: 10.1186/s12885-017-3875-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
97 Verma HK, Ratre YK, Mazzone P, Laurino S, Bhaskar LVKS. Micro RNA facilitated chemoresistance in gastric cancer: a novel biomarkers and potential therapeutics. Alexandria Journal of Medicine 2020;56:81-92. [DOI: 10.1080/20905068.2020.1779992] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
98 Borralho PM, Kren BT, Castro RE, da Silva IB, Steer CJ, Rodrigues CM. MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J. 2009;276:6689-6700. [PMID: 19843160 DOI: 10.1111/j.1742-4658.2009.07383.x] [Cited by in Crossref: 142] [Cited by in F6Publishing: 138] [Article Influence: 10.9] [Reference Citation Analysis]
99 Rama AR, Perazzoli G, Cabeza L, Mesas C, Quiñonero F, García-Pinel B, Vélez C. Novel MicroRNA Sponges to Specifically Modulate Gene Expression in Colon Cancer Cells. Nucleic Acid Ther 2020;30:325-34. [PMID: 32429773 DOI: 10.1089/nat.2020.0861] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
100 Xue F, Yin J, Xu L, Wang B. MicroRNA-143 inhibits tumorigenesis in hepatocellular carcinoma by downregulating GATA6. Exp Ther Med. 2017;13:2667-2674. [PMID: 28587328 DOI: 10.3892/etm.2017.4348] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
101 Xu Y, Deng Y, Yan X, Zhou T. Targeting miR-375 in gastric cancer. Expert Opin Ther Targets 2011;15:961-72. [PMID: 21557705 DOI: 10.1517/14728222.2011.581232] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
102 Minami K, Taniguchi K, Sugito N, Kuranaga Y, Inamoto T, Takahara K, Takai T, Yoshikawa Y, Kiyama S, Akao Y, Azuma H. MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells. Oncotarget 2017;8:33064-77. [PMID: 28380435 DOI: 10.18632/oncotarget.16524] [Cited by in Crossref: 36] [Cited by in F6Publishing: 41] [Article Influence: 9.0] [Reference Citation Analysis]
103 Tekin C, Ercelik M, Tezcan G, Aksoy SA, Egeli U, Cecener G, Tunca B. Olea europaea Leaf Extract Suppress Stemness-Characteristics of Gastric Cancer via Long non-coding RNAs. European Journal of Integrative Medicine 2022. [DOI: 10.1016/j.eujim.2022.102099] [Reference Citation Analysis]
104 Russo A, Bronte G, Cabibi D, Bazan V, Cicero G, Bertani A, Rizzo S, Fiorentino E. The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? Critical Reviews in Oncology/Hematology 2013;86:278-89. [DOI: 10.1016/j.critrevonc.2012.12.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
105 Liu H, Fan YF, Wei MX. Progress in understanding association between microRNAs and gastric cancer. Shijie Huaren Xiaohua Zazhi 2013; 21(23): 2289-2293 [DOI: 10.11569/wcjd.v21.i23.2289] [Reference Citation Analysis]
106 Ling Z, Fan G, Yao D, Zhao J, Zhou Y, Feng J, Zhou G, Chen Y. MicroRNA-150 functions as a tumor suppressor and sensitizes osteosarcoma to doxorubicin-induced apoptosis by targeting RUNX2. Exp Ther Med 2020;19:481-8. [PMID: 31897096 DOI: 10.3892/etm.2019.8231] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
107 Akao Y, Nakagawa Y, Hirata I, Iio A, Itoh T, Kojima K, Nakashima R, Kitade Y, Naoe T. Role of anti-oncomirs miR-143 and -145 in human colorectal tumors. Cancer Gene Ther. 2010;17:398-408. [PMID: 20094072 DOI: 10.1038/cgt.2009.88] [Cited by in Crossref: 187] [Cited by in F6Publishing: 170] [Article Influence: 15.6] [Reference Citation Analysis]
108 He B, Xu Z, Chen J, Zheng D, Li A, Zhang LS. Upregulated microRNA-143 inhibits cell proliferation in human nasopharyngeal carcinoma. Oncol Lett 2016;12:5023-8. [PMID: 28105209 DOI: 10.3892/ol.2016.5363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
109 Li W, Zhang Z, Wang B, Liang N, Zhou Q, Long S. MicroRNA and cyclooxygenase-2 in breast cancer. Clin Chim Acta 2021;522:36-44. [PMID: 34389281 DOI: 10.1016/j.cca.2021.08.007] [Reference Citation Analysis]
110 Ribes À, Santiago-felipe S, Aviñó A, Candela-noguera V, Eritja R, Sancenón F, Martínez-máñez R, Aznar E. Design of oligonucleotide-capped mesoporous silica nanoparticles for the detection of miRNA-145 by duplex and triplex formation. Sensors and Actuators B: Chemical 2018;277:598-603. [DOI: 10.1016/j.snb.2018.09.026] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
111 Lemcke H, Steinhoff G, David R. Gap junctional shuttling of miRNA — A novel pathway of intercellular gene regulation and its prospects in clinical application. Cellular Signalling 2015;27:2506-14. [DOI: 10.1016/j.cellsig.2015.09.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.9] [Reference Citation Analysis]
112 Hatziapostolou M, Polytarchou C, Iliopoulos D. miRNAs link metabolic reprogramming to oncogenesis. Trends Endocrinol Metab 2013;24:361-73. [PMID: 23602813 DOI: 10.1016/j.tem.2013.03.002] [Cited by in Crossref: 52] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
113 Wang Z, Yang B. Detection, Profiling, and Quantification of miRNA Expression. MicroRNA Expression Detection Methods. Berlin: Springer Berlin Heidelberg; 2010. pp. 3-64. [DOI: 10.1007/978-3-642-04928-6_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
114 Iio A, Nakagawa Y, Hirata I, Naoe T, Akao Y. Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer 2010;9:136. [PMID: 20525177 DOI: 10.1186/1476-4598-9-136] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
115 Wang Q, Qin J, Chen A, Zhou J, Liu J, Cheng J, Qiu J, Zhang J. Downregulation of microRNA-145 is associated with aggressive progression and poor prognosis in human cervical cancer. Tumour Biol 2015;36:3703-8. [PMID: 25560490 DOI: 10.1007/s13277-014-3009-3] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
116 Xia H, Sun S, Wang B, Wang T, Liang C, Li G, Huang C, Qi D, Chu X. miR-143 inhibits NSCLC cell growth and metastasis by targeting Limk1. Int J Mol Sci. 2014;15:11973-11983. [PMID: 25003638 DOI: 10.3390/ijms150711973] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
117 Liu X, Wu Y, Zhou Z, Huang M, Deng W, Wang Y, Zhou X, Chen L, Li Y, Zeng T, Wang G, Fu B. Celecoxib inhibits the epithelial-to-mesenchymal transition in bladder cancer via the miRNA-145/TGFBR2/Smad3 axis. Int J Mol Med 2019;44:683-93. [PMID: 31198976 DOI: 10.3892/ijmm.2019.4241] [Cited by in Crossref: 10] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
118 Yang X, Li X, Quan X, Li H, Hao X, Jiang M, Zhou B. Association Between Two Polymorphisms in the Promoter Region of miR-143/miR-145 and the Susceptibility of Lung Cancer in Northeast Chinese Nonsmoking Females. DNA Cell Biol 2019;38:814-23. [PMID: 31314552 DOI: 10.1089/dna.2019.4796] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
119 Peng X, Pentassuglia L, Sawyer DB. Emerging anticancer therapeutic targets and the cardiovascular system: is there cause for concern? Circ Res 2010;106:1022-34. [PMID: 20360265 DOI: 10.1161/CIRCRESAHA.109.211276] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
120 Noto JM, Peek RM. The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis. Front Cell Infect Microbiol. 2011;1:21. [PMID: 22919587 DOI: 10.3389/fcimb.2011.00021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
121 Wang DD, Jiang H, Zhao WY, Song MQ, You FP, Yang YF, Chen LB, Yang L. Correlation between microRNA-377 and histone methyltransferase SMYD3 expression in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(18): 1902-1906 [DOI: 10.11569/wcjd.v18.i18.1902] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
122 Smith CM, Watson DI, Michael MZ, Hussey DJ. MicroRNAs, development of Barrett’s esophagus, and progression to esophageal adenocarcinoma. World J Gastroenterol 2010; 16(5): 531-537 [PMID: 20128019 DOI: 10.3748/wjg.v16.i5.531] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.7] [Reference Citation Analysis]
123 Ali S, Ahmad A, Aboukameel A, Bao B, Padhye S, Philip PA, Sarkar FH. Increased Ras GTPase activity is regulated by miRNAs that can be attenuated by CDF treatment in pancreatic cancer cells. Cancer Lett. 2012;319:173-181. [PMID: 22261338 DOI: 10.1016/j.canlet.2012.01.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 4.5] [Reference Citation Analysis]
124 Cheng Q, Yi B, Wang A, Jiang X. Exploring and exploiting the fundamental role of microRNAs in tumor pathogenesis. Onco Targets Ther 2013;6:1675-84. [PMID: 24273410 DOI: 10.2147/OTT.S52730] [Cited by in Crossref: 9] [Cited by in F6Publishing: 22] [Article Influence: 1.0] [Reference Citation Analysis]
125 Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong RM, Miller KM, Bendor J, Jacks T. Stromal Expression of miR-143/145 Promotes Neoangiogenesis in Lung Cancer Development. Cancer Discov 2016;6:188-201. [PMID: 26586766 DOI: 10.1158/2159-8290.CD-15-0854] [Cited by in Crossref: 78] [Cited by in F6Publishing: 60] [Article Influence: 11.1] [Reference Citation Analysis]
126 Yu Y, Nangia-Makker P, Farhana L, Majumdar APN. A novel mechanism of lncRNA and miRNA interaction: CCAT2 regulates miR-145 expression by suppressing its maturation process in colon cancer cells. Mol Cancer 2017;16:155. [PMID: 28964256 DOI: 10.1186/s12943-017-0725-5] [Cited by in Crossref: 95] [Cited by in F6Publishing: 100] [Article Influence: 19.0] [Reference Citation Analysis]
127 Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, Pan SH, Jiang HC, Liu LX. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells. J Gastroenterol Hepatol. 2011;26:186-193. [PMID: 21175813 DOI: 10.1111/j.1440-1746.2010.06317.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
128 Xu Q, Liu LZ, Qian X, Chen Q, Jiang Y, Li D, Lai L, Jiang BH. MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis. Nucleic Acids Res. 2012;40:761-774. [PMID: 21917858 DOI: 10.1093/nar/gkr730] [Cited by in Crossref: 186] [Cited by in F6Publishing: 187] [Article Influence: 16.9] [Reference Citation Analysis]
129 Lozada-Delgado EL, Grafals-Ruiz N, Miranda-Román MA, Santana-Rivera Y, Valiyeva F, Rivera-Díaz M, Marcos-Martínez MJ, Vivas-Mejía PE. Targeting MicroRNA-143 Leads to Inhibition of Glioblastoma Tumor Progression. Cancers (Basel) 2018;10:E382. [PMID: 30322013 DOI: 10.3390/cancers10100382] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
130 Tsujino T, Sugito N, Taniguchi K, Honda R, Komura K, Yoshikawa Y, Takai T, Minami K, Kuranaga Y, Shinohara H, Tokumaru Y, Heishima K, Inamoto T, Azuma H, Akao Y. MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer. Cancer Sci 2019;110:2189-99. [PMID: 31066120 DOI: 10.1111/cas.14035] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
131 Zhu Z, Xu T, Wang L, Wang X, Zhong S, Xu C, Shen Z. MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells. FEBS Lett 2014;588:3180-5. [PMID: 24999188 DOI: 10.1016/j.febslet.2014.06.059] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
132 Zheng H, Liu Z, Liu T, Cai Y, Wang Y, Lin S, Chen J, Wang J, Wang Z, Jiang B. Fas signaling promotes chemoresistance in gastrointestinal cancer by up-regulating P-glycoprotein. Oncotarget 2014;5:10763-77. [PMID: 25333257 DOI: 10.18632/oncotarget.2498] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
133 Zhou X, Mao Y, Zhu J, Meng F, Chen Q, Tao L, Li R, Fu F, Liu C, Hu Y, Wang W, Zhang H, Hua D, Chen W, Zhang X. TGF-β1 promotes colorectal cancer immune escape by elevating B7-H3 and B7-H4 via the miR-155/miR-143 axis. Oncotarget 2016;7:67196-211. [PMID: 27626488 DOI: 10.18632/oncotarget.11950] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
134 Ruebel K, Leontovich AA, Stilling GA, Zhang S, Righi A, Jin L, Lloyd RV. MicroRNA expression in ileal carcinoid tumors: downregulation of microRNA-133a with tumor progression. Mod Pathol. 2010;23:367-375. [PMID: 20037573 DOI: 10.1038/modpathol.2009.161] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
135 Wang ZH, Zhou L, Wang CF, Zhang LF. Clinical significance of expression of miR-143 in pancreatic carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(10): 1520-1525 [DOI: 10.11569/wcjd.v24.i10.1520] [Reference Citation Analysis]
136 Tazawa H, Kagawa S, Fujiwara T. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors. Expert Opin Biol Ther 2011;11:145-55. [PMID: 21219233 DOI: 10.1517/14712598.2011.542749] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
137 Huang SL, Ye H, Tang YW, Wu LN, Guo WY, Shen XL, Dong XW, Zhang X. Clinical significance of expression of miR-638 in gastric carcinoma. Shijie Huaren Xiaohua Zazhi 2016; 24(6): 928-932 [DOI: 10.11569/wcjd.v24.i6.928] [Reference Citation Analysis]
138 Lin CP, Choi YJ, Hicks GG, He L. The emerging functions of the p53-miRNA network in stem cell biology. Cell Cycle 2012;11:2063-72. [PMID: 22580472 DOI: 10.4161/cc.20207] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
139 Pashaei E, Guzel E, Ozgurses ME, Demirel G, Aydin N, Ozen M. A Meta-Analysis: Identification of Common Mir-145 Target Genes that have Similar Behavior in Different GEO Datasets. PLoS One 2016;11:e0161491. [PMID: 27655328 DOI: 10.1371/journal.pone.0161491] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
140 Zhang R, Wang L, Yang A. Is microRNA-143 really a turncoat of tumor suppressor microRNA in hepatitis B virus-related hepatocellular carcinoma? Hepatology 2009;50:987-987. [DOI: 10.1002/hep.23124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
141 Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One 2012;7:e33762. [PMID: 22438992 DOI: 10.1371/journal.pone.0033762] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 7.3] [Reference Citation Analysis]
142 Zhao H, Cheng Y, Dong S, Du J, Gao F, Sun D, Cui J, Ni J, Cai J. Down regulation of miR-143 promotes radiation - Induced thymic lymphoma by targeting B7H1. Toxicol Lett 2017;280:116-24. [PMID: 28736328 DOI: 10.1016/j.toxlet.2017.07.891] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
143 Chen XL, Zhou X. MicroRNA143 and tumors of the digestive system. Shijie Huaren Xiaohua Zazhi 2014; 22(13): 1806-1811 [DOI: 10.11569/wcjd.v22.i13.1806] [Reference Citation Analysis]
144 Suzuki H, Saito Y, Hibi T. MicroRNAs in Gastric Cancer. In: Cho WC, editor. MicroRNAs in Cancer Translational Research. Dordrecht: Springer Netherlands; 2011. pp. 135-43. [DOI: 10.1007/978-94-007-0298-1_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
145 Sarkar FH, Li Y, Wang Z, Kong D, Ali S. Implication of microRNAs in drug resistance for designing novel cancer therapy. Drug Resist Updat 2010;13:57-66. [PMID: 20236855 DOI: 10.1016/j.drup.2010.02.001] [Cited by in Crossref: 148] [Cited by in F6Publishing: 126] [Article Influence: 12.3] [Reference Citation Analysis]
146 Manvati S, Mangalhara KC, Kalaiarasan P, Chopra R, Agarwal G, Kumar R, Saini SK, Kaushik M, Arora A, Kumari U, Bamezai RNK, Dhar PK. miR-145 supports cancer cell survival and shows association with DDR genes, methylation pattern, and epithelial to mesenchymal transition. Cancer Cell Int 2019;19:230. [PMID: 31516387 DOI: 10.1186/s12935-019-0933-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
147 Taniguchi K, Wada SI, Ito Y, Hayashi J, Inomata Y, Lee SW, Tanaka T, Komura K, Akao Y, Urata H, Uchiyama K. α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in Vitro. Mol Pharm 2019;16:4542-50. [PMID: 31596588 DOI: 10.1021/acs.molpharmaceut.9b00680] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
148 Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II. Therapy resistance mediated by exosomes. Mol Cancer 2019;18:58. [PMID: 30925921 DOI: 10.1186/s12943-019-0970-x] [Cited by in Crossref: 65] [Cited by in F6Publishing: 62] [Article Influence: 21.7] [Reference Citation Analysis]
149 Hartmann D, Thum T. MicroRNAs and vascular (dys)function. Vascul Pharmacol. 2011;55:92-105. [PMID: 21802526 DOI: 10.1016/j.vph.2011.07.005] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
150 Nakagawa Y, Akao Y, Tahara T, Yamashita H, Nagasaka M, Shibata T, Ohmiya N. Development and endoscopic appearance of colorectal tumors are characterized by the expression profiles of miRNAs. Med Mol Morphol 2018;51:82-8. [DOI: 10.1007/s00795-018-0186-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
151 Inamoto T, Taniguchi K, Takahara K, Iwatsuki A, Takai T, Komura K, Yoshikawa Y, Uchimoto T, Saito K, Tanda N, Kouno J, Minami K, Uehara H, Hirano H, Nomi H, Kiyama S, Akao Y, Azuma H. Intravesical administration of exogenous microRNA-145 as a therapy for mouse orthotopic human bladder cancer xenograft. Oncotarget 2015;6:21628-35. [PMID: 26036261 DOI: 10.18632/oncotarget.4129] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
152 Song B, Ju J. Impact of miRNAs in gastrointestinal cancer diagnosis and prognosis. Expert Rev Mol Med 2010;12:e33. [PMID: 20942990 DOI: 10.1017/S1462399410001663] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
153 Pirlog R, Drula R, Nutu A, Calin GA, Berindan-Neagoe I. The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions. Int J Mol Sci 2021;22:12491. [PMID: 34830370 DOI: 10.3390/ijms222212491] [Reference Citation Analysis]
154 Lu Y, Chopp M, Zheng X, Katakowski M, Buller B, Jiang F. MiR-145 reduces ADAM17 expression and inhibits in vitro migration and invasion of glioma cells. Oncol Rep 2013;29:67-72. [PMID: 23076445 DOI: 10.3892/or.2012.2084] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
155 Xu X, Yang X, Xing C, Zhang S, Cao J. miRNA: The nemesis of gastric cancer (Review). Oncol Lett. 2013;6:631-641. [PMID: 24137382 DOI: 10.3892/ol.2013.1428] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
156 Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, Kitade Y, Naoe T, Akao Y. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett. 2011;307:211-220. [PMID: 21550168 DOI: 10.1016/j.canlet.2011.04.005] [Cited by in Crossref: 96] [Cited by in F6Publishing: 92] [Article Influence: 8.7] [Reference Citation Analysis]
157 Miller HC, Frampton AE, Malczewska A, Ottaviani S, Stronach EA, Flora R, Kaemmerer D, Schwach G, Pfragner R, Faiz O. MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. Endocr Relat Cancer. 2016;23:711-726. [PMID: 27353039 DOI: 10.1530/erc-16-0044] [Cited by in Crossref: 36] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
158 da Silva Oliveira KC, Thomaz Araújo TM, Albuquerque CI, Barata GA, Gigek CO, Leal MF, Wisnieski F, Rodrigues Mello Junior FA, Khayat AS, de Assumpção PP, Rodriguez Burbano RM, Smith MC, Calcagno DQ. Role of miRNAs and their potential to be useful as diagnostic and prognostic biomarkers in gastric cancer. World J Gastroenterol 2016; 22(35): 7951-7962 [PMID: 27672290 DOI: 10.3748/wjg.v22.i35.7951] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
159 Wach S, Brandl M, Borchardt H, Weigelt K, Lukat S, Nolte E, Al-Janabi O, Hart M, Grässer F, Giedl J, Jung R, Stöhr R, Hartmann A, Lieb V, Höbel S, Peters A, Stäubert C, Wullich B, Taubert H, Aigner A. Exploring the MIR143-UPAR Axis for the Inhibition of Human Prostate Cancer Cells In Vitro and In Vivo. Mol Ther Nucleic Acids 2019;16:272-83. [PMID: 30933831 DOI: 10.1016/j.omtn.2019.02.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
160 Wang T, Zang WQ, Li M, Wang N, Zheng YL, Zhao GQ. Effect of miR-451 on the biological behavior of the esophageal carcinoma cell line EC9706. Dig Dis Sci. 2013;58:706-714. [PMID: 23053883 DOI: 10.1007/s10620-012-2395-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
161 Zhong X, Wen X, Chen L, Gu N, Yu X, Sui K. Long non-coding RNA KCNQ1OT1 promotes the progression of gastric cancer via the miR-145-5p/ARF6 axis.J Gene Med. 2021;23:e3330. [PMID: 33682985 DOI: 10.1002/jgm.3330] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
162 Cui SY, Wang R, Chen LB. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med. 2014;18:1913-1926. [PMID: 25124875 DOI: 10.1111/jcmm.12358] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 8.9] [Reference Citation Analysis]
163 Wu X, Shen J, Xiao Z, Li J, Zhao Y, Zhao Q, Cho CH, Li M. An overview of the multifaceted roles of miRNAs in gastric cancer: Spotlight on novel biomarkers and therapeutic targets. Biochem Pharmacol 2019;163:425-39. [PMID: 30857828 DOI: 10.1016/j.bcp.2019.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
164 Zhao X, Zhang W, Ji W. MYO5A inhibition by miR-145 acts as a predictive marker of occult neck lymph node metastasis in human laryngeal squamous cell carcinoma. Onco Targets Ther 2018;11:3619-35. [PMID: 29950866 DOI: 10.2147/OTT.S164597] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
165 Liu J, Mao Y, Zhang D, Hao S, Zhang Z, Li Z, Li B. MiR-143 inhibits tumor cell proliferation and invasion by targeting STAT3 in esophageal squamous cell carcinoma. Cancer Lett. 2016;373:97-108. [PMID: 26806810 DOI: 10.1016/j.canlet.2016.01.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
166 Peng X, Guo W, Liu T, Wang X, Tu X, Xiong D, Chen S, Lai Y, Du H, Chen G, Liu G, Tang Y, Huang S, Zou X. Identification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMT. PLoS One 2011;6:e20341. [PMID: 21647377 DOI: 10.1371/journal.pone.0020341] [Cited by in Crossref: 153] [Cited by in F6Publishing: 151] [Article Influence: 13.9] [Reference Citation Analysis]
167 Albulescu R, Neagu M, Albulescu L, Tanase C. Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers. Expert Rev Mol Diagn. 2011;11:101-120. [PMID: 21171925 DOI: 10.1586/erm.10.106] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
168 Dombkowski AA, Sultana Z, Craig DB, Jamil H. In silico analysis of combinatorial microRNA activity reveals target genes and pathways associated with breast cancer metastasis. Cancer Inform 2011;10:13-29. [PMID: 21552493 DOI: 10.4137/CIN.S6631] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
169 Ngalame NN, Makia NL, Waalkes MP, Tokar EJ. Mitigation of arsenic-induced acquired cancer phenotype in prostate cancer stem cells by miR-143 restoration. Toxicol Appl Pharmacol 2016;312:11-8. [PMID: 26721309 DOI: 10.1016/j.taap.2015.12.013] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 2.6] [Reference Citation Analysis]
170 Ali SR, Humphreys KJ, McKinnon RA, Michael MZ. Impact of Histone Deacetylase Inhibitors on microRNA Expression and Cancer Therapy: A Review. Drug Dev Res. 2015;76:296-317. [PMID: 26303212 DOI: 10.1002/ddr.21268] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.1] [Reference Citation Analysis]
171 Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C, Li H, Shi DB. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene. 2013;32:491-501. [PMID: 22370644 DOI: 10.1038/onc.2012.61] [Cited by in Crossref: 102] [Cited by in F6Publishing: 104] [Article Influence: 10.2] [Reference Citation Analysis]
172 Tavano F, di Mola FF, Piepoli A, Panza A, Copetti M, Burbaci FP, Latiano T, Pellegrini F, Maiello E, Andriulli A. Changes in miR-143 and miR-21 expression and clinicopathological correlations in pancreatic cancers. Pancreas. 2012;41:1280-1284. [PMID: 22836856 DOI: 10.1097/mpa.0b013e31824c11f4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
173 Götte M, Mohr C, Koo CY, Stock C, Vaske AK, Viola M, Ibrahim SA, Peddibhotla S, Teng YH, Low JY, Ebnet K, Kiesel L, Yip GW. miR-145-dependent targeting of junctional adhesion molecule A and modulation of fascin expression are associated with reduced breast cancer cell motility and invasiveness. Oncogene 2010;29:6569-80. [PMID: 20818426 DOI: 10.1038/onc.2010.386] [Cited by in Crossref: 153] [Cited by in F6Publishing: 149] [Article Influence: 12.8] [Reference Citation Analysis]
174 Pan SF, Sui H, Li Q, Shi XL. Progress in understanding role of microRNAs in multidrug resistance in digestive system cancers. Shijie Huaren Xiaohua Zazhi 2013; 21(19): 1834-1840 [DOI: 10.11569/wcjd.v21.i19.1834] [Reference Citation Analysis]
175 Guoping M, Ran L, Yanru Q. miR-143 Inhibits Cell Proliferation of Gastric Cancer Cells Through Targeting GATA6. Oncol Res 2018;26:1023-9. [PMID: 29321084 DOI: 10.3727/096504018X15151515028670] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
176 Wu XL, Cheng B, Li PY, Huang HJ, Zhao Q, Dan ZL, Tian DA, Zhang P. MicroRNA-143 suppresses gastric cancer cell growth and induces apoptosis by targeting COX-2. World J Gastroenterol 2013; 19(43): 7758-7765 [PMID: 24616567 DOI: 10.3748/wjg.v19.i43.7758] [Cited by in CrossRef: 73] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
177 Skjefstad K, Johannessen C, Grindstad T, Kilvaer T, Paulsen EE, Pedersen M, Donnem T, Andersen S, Bremnes R, Richardsen E, Al-Saad S, Busund LT. A gender specific improved survival related to stromal miR-143 and miR-145 expression in non-small cell lung cancer. Sci Rep 2018;8:8549. [PMID: 29867125 DOI: 10.1038/s41598-018-26864-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
178 Riquelme I, Letelier P, Riffo-Campos AL, Brebi P, Roa JC. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer. Int J Mol Sci. 2016;17:424. [PMID: 27011182 DOI: 10.3390/ijms17030424] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 10.3] [Reference Citation Analysis]
179 Taniguchi K, Sugito N, Shinohara H, Kuranaga Y, Inomata Y, Komura K, Uchiyama K, Akao Y. Organ-Specific MicroRNAs (MIR122, 137, and 206) Contribute to Tissue Characteristics and Carcinogenesis by Regulating Pyruvate Kinase M1/2 (PKM) Expression. Int J Mol Sci 2018;19:E1276. [PMID: 29695138 DOI: 10.3390/ijms19051276] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
180 Liu R, Liao J, Yang M, Sheng J, Yang H, Wang Y, Pan E, Guo W, Pu Y, Kim SJ. The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One. 2012;7:e33987. [PMID: 22457808 DOI: 10.1371/journal.pone.0033987] [Cited by in Crossref: 74] [Cited by in F6Publishing: 77] [Article Influence: 7.4] [Reference Citation Analysis]
181 Tchernitsa O, Kasajima A, Schäfer R, Kuban RJ, Ungethüm U, Györffy B, Neumann U, Simon E, Weichert W, Ebert MP. Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression. J Pathol. 2010;222:310-319. [PMID: 20726036 DOI: 10.1002/path.2759] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 7.9] [Reference Citation Analysis]
182 Zhang C. MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle 2009;8:3469-73. [PMID: 19829088 DOI: 10.4161/cc.8.21.9837] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 4.8] [Reference Citation Analysis]
183 Ida H, Tanabe T, Tachibana A. Improved cancer inhibition by miR-143 with a longer passenger strand than natural miR-143. Biochem Biophys Res Commun 2020;524:810-5. [PMID: 32037092 DOI: 10.1016/j.bbrc.2020.02.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Loureiro D, Tout I, Narguet S, Benazzouz SM, Mansouri A, Asselah T. miRNAs as Potential Biomarkers for Viral Hepatitis B and C. Viruses 2020;12:E1440. [PMID: 33327640 DOI: 10.3390/v12121440] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
185 Tsai MM, Wang CS, Tsai CY, Huang HW, Chi HC, Lin YH, Lu PH, Lin KH. Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer. Int J Mol Sci. 2016;17:pii: E945. [PMID: 27322246 DOI: 10.3390/ijms17060945] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 12.0] [Reference Citation Analysis]
186 Naidu S, Magee P, Garofalo M. MiRNA-based therapeutic intervention of cancer. J Hematol Oncol 2015;8:68. [PMID: 26062952 DOI: 10.1186/s13045-015-0162-0] [Cited by in Crossref: 73] [Cited by in F6Publishing: 68] [Article Influence: 10.4] [Reference Citation Analysis]
187 Akagi I, Miyashita M, Ishibashi O, Mishima T, Kikuchi K, Makino H, Nomura T, Hagiwara N, Uchida E, Takizawa T. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis Esophagus. 2011;24:523-530. [PMID: 21453382 DOI: 10.1111/j.1442-2050.2011.01177.x] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 3.5] [Reference Citation Analysis]
188 Brenner B, Hoshen MB, Purim O, David MB, Ashkenazi K, Marshak G, Kundel Y, Brenner R, Morgenstern S, Halpern M, Rosenfeld N, Chajut A, Niv Y, Kushnir M. MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol 2011; 17(35): 3976-3985 [PMID: 22046085 DOI: 10.3748/wjg.v17.i35.3976] [Cited by in CrossRef: 67] [Cited by in F6Publishing: 62] [Article Influence: 6.1] [Reference Citation Analysis]
189 Ouyang L, Liu P, Yang S, Ye S, Xu W, Liu X. A three-plasma miRNA signature serves as novel biomarkers for osteosarcoma. Med Oncol 2013;30. [DOI: 10.1007/s12032-012-0340-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 85] [Article Influence: 8.3] [Reference Citation Analysis]
190 Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J, Sung JJ. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene. 2010;29:5761-5771. [PMID: 20802530 DOI: 10.1038/onc.2010.352] [Cited by in Crossref: 196] [Cited by in F6Publishing: 197] [Article Influence: 16.3] [Reference Citation Analysis]
191 Khan SA, Tyagi M, Sharma AK, Barreto SG, Sirohi B, Ramadwar M, Shrikhande SV, Gupta S. Cell-type specificity of β-actin expression and its clinicopathological correlation in gastric adenocarcinoma. World J Gastroenterol 2014; 20(34): 12202-12211 [PMID: 25232253 DOI: 10.3748/wjg.v20.i34.12202] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
192 Zeng JF, Ma XQ, Wang LP, Wang W. MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering effects by targeting CD44 in gastric cancer. World J Gastroenterol 2017; 23(13): 2337-2345 [PMID: 28428713 DOI: 10.3748/wjg.v23.i13.2337] [Cited by in CrossRef: 28] [Cited by in F6Publishing: 29] [Article Influence: 5.6] [Reference Citation Analysis]
193 Chen LH, Tsai KL, Chen YW, Yu CC, Chang KW, Chiou SH, Ku HH, Chu PY, Tseng LM, Huang PI, Lo WL. MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma. J Oncol 2010;2010:135632. [PMID: 21461395 DOI: 10.1155/2010/135632] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
194 Liu Y, Li X, Feng X, Wang L. A Novel Neighborhood-Based Computational Model for Potential MiRNA-Disease Association Prediction. Comput Math Methods Med 2019;2019:5145646. [PMID: 30800172 DOI: 10.1155/2019/5145646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
195 Naito Y, Sakamoto N, Oue N, Yashiro M, Sentani K, Yanagihara K, Hirakawa K, Yasui W. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci. 2014;105:228-235. [PMID: 24283360 DOI: 10.1111/cas.12329] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 5.9] [Reference Citation Analysis]
196 Qi J, Mu D. MicroRNAs and lung cancers: from pathogenesis to clinical implications. Front Med 2012;6:134-55. [PMID: 22528868 DOI: 10.1007/s11684-012-0188-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 2.9] [Reference Citation Analysis]
197 Wang W, Wu S, Shi Y, Miao Y, Luo X, Ji M, Yao K, He J. c-MYB regulates cell growth and DNA damage repair through modulating MiR-143. FEBS Lett 2015;589:555-64. [PMID: 25616133 DOI: 10.1016/j.febslet.2015.01.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
198 Taniguchi K, Ito Y, Sugito N, Kumazaki M, Shinohara H, Yamada N, Nakagawa Y, Sugiyama T, Futamura M, Otsuki Y, Yoshida K, Uchiyama K, Akao Y. Organ-specific PTB1-associated microRNAs determine expression of pyruvate kinase isoforms. Sci Rep 2015;5:8647. [PMID: 25721733 DOI: 10.1038/srep08647] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 4.9] [Reference Citation Analysis]
199 Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, Yonemura J, Ishizuka T, Arisawa T, Hirata I. Association between common genetic variants in pre-microRNAs and gastric cancer risk in Japanese population. Helicobacter. 2010;15:524-531. [PMID: 21073609 DOI: 10.1111/j.1523-5378.2010.00806.x] [Cited by in Crossref: 115] [Cited by in F6Publishing: 112] [Article Influence: 10.5] [Reference Citation Analysis]
200 Taniguchi K, Sakai M, Sugito N, Kumazaki M, Shinohara H, Yamada N, Nakayama T, Ueda H, Nakagawa Y, Ito Y, Futamura M, Uno B, Otsuki Y, Yoshida K, Uchiyama K, Akao Y. PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors. Oncotarget 2016;7:18940-52. [PMID: 26980745 DOI: 10.18632/oncotarget.8005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
201 Lang W, Chen F. The reciprocal link between EVI1 and miRNAs in human malignancies. Gene 2018;672:56-63. [DOI: 10.1016/j.gene.2018.06.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
202 Nakagawa Y, Kuranaga Y, Tahara T, Yamashita H, Shibata T, Nagasaka M, Funasaka K, Ohmiya N, Akao Y. Induced miR-31 by 5-fluorouracil exposure contributes to the resistance in colorectal tumors. Cancer Sci 2019;110:2540-8. [PMID: 31162779 DOI: 10.1111/cas.14090] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
203 Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-130. [PMID: 16514137 DOI: 10.1007/s11010-010-0463-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
204 Nakagawa Y, Akao Y, Taniguchi K, Kamatani A, Tahara T, Kamano T, Nakano N, Komura N, Ikuno H, Ohmori T. Relationship between expression of onco-related miRNAs and the endoscopic appearance of colorectal tumors. Int J Mol Sci. 2015;16:1526-1543. [PMID: 25584614 DOI: 10.3390/ijms16011526] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
205 Alessandrini L, Manchi M, De Re V, Dolcetti R, Canzonieri V. Proposed Molecular and miRNA Classification of Gastric Cancer. Int J Mol Sci 2018;19:E1683. [PMID: 29882766 DOI: 10.3390/ijms19061683] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 6.5] [Reference Citation Analysis]
206 Bazot Q, Paschos K, Skalska L, Kalchschmidt JS, Parker GA, Allday MJ. Epstein-Barr Virus Proteins EBNA3A and EBNA3C Together Induce Expression of the Oncogenic MicroRNA Cluster miR-221/miR-222 and Ablate Expression of Its Target p57KIP2. PLoS Pathog 2015;11:e1005031. [PMID: 26153983 DOI: 10.1371/journal.ppat.1005031] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
207 Sikand K, Singh J, Ebron JS, Shukla GC. Housekeeping gene selection advisory: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and β-actin are targets of miR-644a. PLoS One. 2012;7:e47510. [PMID: 23091630 DOI: 10.1371/journal.pone.0047510] [Cited by in Crossref: 52] [Cited by in F6Publishing: 46] [Article Influence: 5.2] [Reference Citation Analysis]
208 Khordadmehr M, Jigari-Asl F, Ezzati H, Shahbazi R, Sadreddini S, Safaei S, Baradaran B. A comprehensive review on miR-451: A promising cancer biomarker with therapeutic potential. J Cell Physiol 2019;234:21716-31. [PMID: 31140618 DOI: 10.1002/jcp.28888] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
209 Ye D, Shen Z, Zhou S. Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment. Cancer Manag Res 2019;11:969-79. [PMID: 30774425 DOI: 10.2147/CMAR.S191696] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]